Skip to content

Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Home (current)
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    Stroke
    Neuromuscular Disorders
    Movement Disorders
    View all Diseases
  • Topics
    Biology
    Diagnostics
    Trial Updates
    Treatment
    Prevention
    Surgery
    Imaging
    Genetics
    COVID-19
    View all Topics
  • Conferences
    AAN 2023
    BNA 2023
    AD/PD 2023
    CONy 2023
    ACTRIMS 2023
    ISC 2023
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Psychiatric Disorders

Phenotyping the prodrome could lead to earlier recognition of MS 3:41
Phenotyping the prodrome could lead to earlier recognition of MS
Anibal Chertcoff • 27 Feb 2023
The burden of psychiatric morbidity in the MS prodrome 4:55
The burden of psychiatric morbidity in the MS prodrome
Anibal Chertcoff • 27 Feb 2023
Major global burden of postpartum depression 2:37
Major global burden of postpartum depression
Gisèle Apter • 25 Nov 2022
Unmet needs in postpartum depression screening and diagnosis 7:34
Unmet needs in postpartum depression screening and diagnosis
Gisèle Apter • 25 Nov 2022
Current and emerging treatment options for peripartum depression 14:34
Current and emerging treatment options for peripartum depression
Gisèle Apter • 25 Nov 2022
Towards early screening for postpartum depression 3:34
Towards early screening for postpartum depression
Gisèle Apter • 25 Nov 2022
Psychedelic-based therapy for the treatment of depression 3:28
Psychedelic-based therapy for the treatment of depression
Ellen James • 19 Oct 2022
Potential benefits of psychedelics over conventional antidepressants 1:24
Potential benefits of psychedelics over conventional antidepressants
Ellen James • 19 Oct 2022
Underlying mechanisms of brain fog 7:31
Underlying mechanisms of brain fog
Sabina Brennan • 28 Oct 2022
Lifestyle strategies for coping with brain fog 8:48
Lifestyle strategies for coping with brain fog
Sabina Brennan • 28 Oct 2022
The burden of psychiatric comorbidities in epilepsy 2:43
The burden of psychiatric comorbidities in epilepsy
Jay Salpekar • 13 Dec 2022
What is brain fog? 5:12
What is brain fog?
Sabina Brennan • 28 Oct 2022
The causes of brain fog 6:20
The causes of brain fog
Sabina Brennan • 28 Nov 2022
World’s first trial of DMT-assisted psychedelic therapy in major depressive disorder: Phase I data 5:31
World’s first trial of DMT-assisted psychedelic therapy in major depressive disorder: Phase I data
Ellen James • 19 Oct 2022
Barriers to psychedelic research 2:13
Barriers to psychedelic research
Ellen James • 19 Oct 2022
The role of the dorsal anterior insular in network coordination 4:39
The role of the dorsal anterior insular in network coordination
Lucina Qazi Uddin • 19 Oct 2022
  • 1
  • 2
  • 3
  • 4
  • Next
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy